BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37000082)

  • 41. [The clinical efficacy of the patients of acute myeloid leukemia and myelodysplastic syndromes treated with decitabine alone, combined with half or one couse of CAG regimen].
    Gao S; Qiu H; Jin Z; Tang X; Fu Z; Ma X; Han Y; Chen S; Sun A; Wu D
    Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):961-5. PubMed ID: 25417868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical analysis of recombinant humanized thrombopoietin for treating 25 children with severe immune thrombocytopenia].
    Zheng J; Ma JY; Su Y; Yang J; Zhang RD; Zhou X; Wu RH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):393-8. PubMed ID: 24763011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial).
    Zhou Z; Feng T; Xie Y; Huang P; Xie H; Tian R; Qian B; Wang R
    BMC Infect Dis; 2019 Sep; 19(1):780. PubMed ID: 31492102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
    Vadhan-Raj S; Verschraegen CF; Bueso-Ramos C; Broxmeyer HE; Kudelkà AP; Freedman RS; Edwards CL; Gershenson D; Jones D; Ashby M; Kavanagh JJ
    Ann Intern Med; 2000 Mar; 132(5):364-8. PubMed ID: 10691586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison of efficacy and safety of two different dose of recombinant human thrombopoietin regimens in severe aplastic anemia patients with immunosuppressive therapy].
    Zhou K; Li Y; Li JP; Fan HH; Zhang L; Jing LP; Peng GX; Ye L; Li Y; Song L; Zhao X; Yang WR; Wu ZJ; Chen F; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):205-9. PubMed ID: 27033757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.
    Wolff SN; Herzig R; Lynch J; Ericson SG; Greer JP; Stein R; Goodman S; Benyunes MC; Ashby M; Jones DV; Fay J
    Bone Marrow Transplant; 2001 Feb; 27(3):261-8. PubMed ID: 11277173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia.
    Wang S; Yang R; Zou P; Hou M; Wu D; Shen Z; Lu X; Li Y; Chen X; Niu T; Sun H; Yu L; Wang Z; Zhang Y; Chang N; Zhang G; Zhao Y
    Int J Hematol; 2012 Aug; 96(2):222-8. PubMed ID: 22753022
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant human thrombopoietin promotes platelet engraftment after umbilical cord blood transplantation.
    Tang B; Huang L; Liu H; Cheng S; Song K; Zhang X; Yao W; Ning L; Wan X; Sun G; Wu Y; Cheng J; Long Q; Sun Z; Zhu X
    Blood Adv; 2020 Aug; 4(16):3829-3839. PubMed ID: 32790845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy.
    Fenaux P; Muus P; Kantarjian H; Lyons RM; Larson RA; Sekeres MA; Becker PS; Orejudos A; Franklin J
    Br J Haematol; 2017 Sep; 178(6):906-913. PubMed ID: 28616874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients with Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study.
    Liu X; Shi H; Shen J; Li Y; Yan W; Sun Y; Liao A; Tan Y; Yang W; Wang H
    Int J Gen Med; 2021; 14():6093-6099. PubMed ID: 34611424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The role of recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: a clinical study].
    Dong F; Ma N; Chang S; Yang H; Gao M; Liu Q; Sun X; Liang M; Sun R
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1445-1449. PubMed ID: 33541495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis.
    van de Ven C; Fernandez GW; Herbst T; Knoppel A; Cairo MS
    Exp Hematol; 1997 Aug; 25(9):1005-12. PubMed ID: 9257814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of Recombinant Human Thrombopoietin for the Treatment of Secondary Failure of Platelet Recovery After Allogeneic HSCT.
    Cao Y; Wang M; Shen B; Zhao F; Zhang R; Chen X; He Y; Zhai W; Ma Q; Wei J; Huang Y; Yang D; Pang A; Feng S; Jiang E; Han M
    Clin Appl Thromb Hemost; 2022; 28():10760296211068037. PubMed ID: 35019756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Administration of recombinant human thrombopoietin is associated with alleviated thrombocytopenia in adult intensive care unit patients with pneumonia: A single-center retrospective study.
    Chen B; Xuan J; Wu F; Shi N; Dai J; Cai S; An S; Huang Q; Huang X; Chen Z; Zeng Z
    Front Pharmacol; 2022; 13():1007719. PubMed ID: 36299903
    [No Abstract]   [Full Text] [Related]  

  • 55. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study.
    Ding JN; Feng TT; Sun W; Cai XY; Zhang Y; Zhao WF
    World J Gastrointest Surg; 2022 Nov; 14(11):1260-1271. PubMed ID: 36504518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine.
    Greenberg PL; Garcia-Manero G; Moore M; Damon L; Roboz G; Hu K; Yang AS; Franklin J
    Leuk Lymphoma; 2013 Feb; 54(2):321-8. PubMed ID: 22906162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High- vs regular-dose recombinant human thrombopoietin plus cyclosporine A in patients with newly diagnosed non-severe aplastic anemia: a retrospective cohort study.
    Yang Y; Hu Q; Yang C; Chen M; Han B
    Hematology; 2024 Dec; 29(1):2298523. PubMed ID: 38156735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
    Xu YH; Chen ZW; Ye XY; Lu S
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):716-9. PubMed ID: 19173920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decitabine in the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndromes, Which Combined with Complex Karyotype Respectively.
    Gao S; Li Z; Fu JH; Hu XH; Xu Y; Jin ZM; Tang XW; Han Y; Chen SN; Sun AN; Wu DP; Qiu HY
    Asian Pac J Cancer Prev; 2015; 16(15):6627-32. PubMed ID: 26434886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A multi-center clinical trial of recombinant human thrombopoietin in chronic refractory idiopathic thrombocytopenic purpura].
    Zhao YQ; Wang QY; Zhai M; Xu J; Chen XQ; Liu WL; Zhang M; Song SJ; Wang JM; Meng FY; Shan YD
    Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):608-10. PubMed ID: 15355668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.